The Market Reports

Index

1 Vigabatrin Market Overview
1.1 Product Overview and Scope of Vigabatrin
1.2 Vigabatrin Segment by Type
1.2.1 Global Vigabatrin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Tablet
1.2.3 Powder
1.3 Vigabatrin Segment by Application
1.3.1 Vigabatrin Sales Comparison by Application: (2021-2027)
1.3.2 Infantile Spasms (IS)
1.3.3 Partial-Onset Seizures
1.3.4 Refractory Complex Partial Seizures
1.4 Global Vigabatrin Market Size Estimates and Forecasts
1.4.1 Global Vigabatrin Revenue 2016-2027
1.4.2 Global Vigabatrin Sales 2016-2027
1.4.3 Vigabatrin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Vigabatrin Market Competition by Manufacturers
2.1 Global Vigabatrin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Vigabatrin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Vigabatrin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Vigabatrin Manufacturing Sites, Area Served, Product Type
2.5 Vigabatrin Market Competitive Situation and Trends
2.5.1 Vigabatrin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Vigabatrin Players Market Share by Revenue
2.5.3 Global Vigabatrin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Vigabatrin Retrospective Market Scenario by Region
3.1 Global Vigabatrin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Vigabatrin Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Vigabatrin Market Facts & Figures by Country
3.3.1 North America Vigabatrin Sales by Country
3.3.2 North America Vigabatrin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vigabatrin Market Facts & Figures by Country
3.4.1 Europe Vigabatrin Sales by Country
3.4.2 Europe Vigabatrin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vigabatrin Market Facts & Figures by Region
3.5.1 Asia Pacific Vigabatrin Sales by Region
3.5.2 Asia Pacific Vigabatrin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vigabatrin Market Facts & Figures by Country
3.6.1 Latin America Vigabatrin Sales by Country
3.6.2 Latin America Vigabatrin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Vigabatrin Market Facts & Figures by Country
3.7.1 Middle East and Africa Vigabatrin Sales by Country
3.7.2 Middle East and Africa Vigabatrin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Vigabatrin Historic Market Analysis by Type
4.1 Global Vigabatrin Sales Market Share by Type (2016-2021)
4.2 Global Vigabatrin Revenue Market Share by Type (2016-2021)
4.3 Global Vigabatrin Price by Type (2016-2021)

5 Global Vigabatrin Historic Market Analysis by Application
5.1 Global Vigabatrin Sales Market Share by Application (2016-2021)
5.2 Global Vigabatrin Revenue Market Share by Application (2016-2021)
5.3 Global Vigabatrin Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Vigabatrin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Benta Pharma Industries
6.2.1 Benta Pharma Industries Corporation Information
6.2.2 Benta Pharma Industries Description and Business Overview
6.2.3 Benta Pharma Industries Vigabatrin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Benta Pharma Industries Product Portfolio
6.2.5 Benta Pharma Industries Recent Developments/Updates
6.3 Dr. Fisher Farma
6.3.1 Dr. Fisher Farma Corporation Information
6.3.2 Dr. Fisher Farma Description and Business Overview
6.3.3 Dr. Fisher Farma Vigabatrin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Dr. Fisher Farma Product Portfolio
6.3.5 Dr. Fisher Farma Recent Developments/Updates
6.4 Lundbeck
6.4.1 Lundbeck Corporation Information
6.4.2 Lundbeck Description and Business Overview
6.4.3 Lundbeck Vigabatrin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lundbeck Product Portfolio
6.4.5 Lundbeck Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Vigabatrin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Novartis Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Perrigo
6.6.1 Perrigo Corporation Information
6.6.2 Perrigo Description and Business Overview
6.6.3 Perrigo Vigabatrin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Perrigo Product Portfolio
6.6.5 Perrigo Recent Developments/Updates
6.7 Grindeks
6.6.1 Grindeks Corporation Information
6.6.2 Grindeks Description and Business Overview
6.6.3 Grindeks Vigabatrin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Grindeks Product Portfolio
6.7.5 Grindeks Recent Developments/Updates
6.8 Endo International
6.8.1 Endo International Corporation Information
6.8.2 Endo International Description and Business Overview
6.8.3 Endo International Vigabatrin Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Endo International Product Portfolio
6.8.5 Endo International Recent Developments/Updates
6.9 Amneal Pharma
6.9.1 Amneal Pharma Corporation Information
6.9.2 Amneal Pharma Description and Business Overview
6.9.3 Amneal Pharma Vigabatrin Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Amneal Pharma Product Portfolio
6.9.5 Amneal Pharma Recent Developments/Updates
6.10 Cipla
6.10.1 Cipla Corporation Information
6.10.2 Cipla Description and Business Overview
6.10.3 Cipla Vigabatrin Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Cipla Product Portfolio
6.10.5 Cipla Recent Developments/Updates
6.11 Upsher-Smith
6.11.1 Upsher-Smith Corporation Information
6.11.2 Upsher-Smith Vigabatrin Description and Business Overview
6.11.3 Upsher-Smith Vigabatrin Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Upsher-Smith Product Portfolio
6.11.5 Upsher-Smith Recent Developments/Updates

7 Vigabatrin Manufacturing Cost Analysis
7.1 Vigabatrin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vigabatrin
7.4 Vigabatrin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Vigabatrin Distributors List
8.3 Vigabatrin Customers

9 Vigabatrin Market Dynamics
9.1 Vigabatrin Industry Trends
9.2 Vigabatrin Growth Drivers
9.3 Vigabatrin Market Challenges
9.4 Vigabatrin Market Restraints

10 Global Market Forecast
10.1 Vigabatrin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vigabatrin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Vigabatrin by Type (2022-2027)
10.2 Vigabatrin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vigabatrin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Vigabatrin by Application (2022-2027)
10.3 Vigabatrin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vigabatrin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Vigabatrin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Vigabatrin Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Vigabatrin Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Vigabatrin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Vigabatrin Covered in This Study
Table 5. Global Vigabatrin Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Vigabatrin Sales Share by Manufacturers (2016-2021)
Table 7. Global Vigabatrin Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Vigabatrin Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Vigabatrin Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Vigabatrin Manufacturing Sites and Area Served
Table 11. Manufacturers Vigabatrin Product Type
Table 12. Global Vigabatrin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Vigabatrin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vigabatrin as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Vigabatrin Sales by Region (2016-2021) & (K Units)
Table 16. Global Vigabatrin Sales Market Share by Region (2016-2021)
Table 17. Global Vigabatrin Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Vigabatrin Sales by Country (2016-2021) & (K Units)
Table 19. North America Vigabatrin Sales Market Share by Country (2016-2021)
Table 20. North America Vigabatrin Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Vigabatrin Revenue Market Share by Country (2016-2021)
Table 22. Europe Vigabatrin Sales by Country (2016-2021) & (K Units)
Table 23. Europe Vigabatrin Sales Market Share by Country (2016-2021)
Table 24. Europe Vigabatrin Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Vigabatrin Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Vigabatrin Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Vigabatrin Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Vigabatrin Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Vigabatrin Revenue Market Share by Region (2016-2021)
Table 30. Latin America Vigabatrin Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Vigabatrin Sales Market Share by Country (2016-2021)
Table 32. Latin America Vigabatrin Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Vigabatrin Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Vigabatrin Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Vigabatrin Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Vigabatrin Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Vigabatrin Revenue Market Share by Country (2016-2021)
Table 38. Global Vigabatrin Sales (K Units) by Type (2016-2021)
Table 39. Global Vigabatrin Sales Market Share by Type (2016-2021)
Table 40. Global Vigabatrin Revenue (Million US$) by Type (2016-2021)
Table 41. Global Vigabatrin Revenue Share by Type (2016-2021)
Table 42. Global Vigabatrin Price (US$/Unit) by Type (2016-2021)
Table 43. Global Vigabatrin Sales (K Units) by Application (2016-2021)
Table 44. Global Vigabatrin Sales Market Share by Application (2016-2021)
Table 45. Global Vigabatrin Revenue (Million US$) by Application (2016-2021)
Table 46. Global Vigabatrin Revenue Share by Application (2016-2021)
Table 47. Global Vigabatrin Price (US$/Unit) by Application (2016-2021)
Table 48. Sanofi Corporation Information
Table 49. Sanofi Description and Business Overview
Table 50. Sanofi Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Sanofi Vigabatrin Product
Table 52. Sanofi Recent Developments/Updates
Table 53. Benta Pharma Industries Corporation Information
Table 54. Benta Pharma Industries Description and Business Overview
Table 55. Benta Pharma Industries Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Benta Pharma Industries Vigabatrin Product
Table 57. Benta Pharma Industries Recent Developments/Updates
Table 58. Dr. Fisher Farma Corporation Information
Table 59. Dr. Fisher Farma Description and Business Overview
Table 60. Dr. Fisher Farma Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Dr. Fisher Farma Vigabatrin Product
Table 62. Dr. Fisher Farma Recent Developments/Updates
Table 63. Lundbeck Corporation Information
Table 64. Lundbeck Description and Business Overview
Table 65. Lundbeck Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Lundbeck Vigabatrin Product
Table 67. Lundbeck Recent Developments/Updates
Table 68. Novartis Corporation Information
Table 69. Novartis Description and Business Overview
Table 70. Novartis Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Novartis Vigabatrin Product
Table 72. Novartis Recent Developments/Updates
Table 73. Perrigo Corporation Information
Table 74. Perrigo Description and Business Overview
Table 75. Perrigo Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Perrigo Vigabatrin Product
Table 77. Perrigo Recent Developments/Updates
Table 78. Grindeks Corporation Information
Table 79. Grindeks Description and Business Overview
Table 80. Grindeks Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Grindeks Vigabatrin Product
Table 82. Grindeks Recent Developments/Updates
Table 83. Endo International Corporation Information
Table 84. Endo International Description and Business Overview
Table 85. Endo International Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Endo International Vigabatrin Product
Table 87. Endo International Recent Developments/Updates
Table 88. Amneal Pharma Corporation Information
Table 89. Amneal Pharma Description and Business Overview
Table 90. Amneal Pharma Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Amneal Pharma Vigabatrin Product
Table 92. Amneal Pharma Recent Developments/Updates
Table 93. Cipla Corporation Information
Table 94. Cipla Description and Business Overview
Table 95. Cipla Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Cipla Vigabatrin Product
Table 97. Cipla Recent Developments/Updates
Table 98. Upsher-Smith Corporation Information
Table 99. Upsher-Smith Description and Business Overview
Table 100. Upsher-Smith Vigabatrin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Upsher-Smith Vigabatrin Product
Table 102. Upsher-Smith Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Vigabatrin Distributors List
Table 106. Vigabatrin Customers List
Table 107. Vigabatrin Market Trends
Table 108. Vigabatrin Growth Drivers
Table 109. Vigabatrin Market Restraints
Table 110. Global Vigabatrin Sales Forecast by Type (2022-2027) & (K Units)
Table 111. Global Vigabatrin Sales Market Share Forecast by Type (2022-2027)
Table 112. Global Vigabatrin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 113. Global Vigabatrin Revenue Market Share Forecast by Type (2022-2027)
Table 114. Global Vigabatrin Sales Forecast by Application (2022-2027) & (K Units)
Table 115. Global Vigabatrin Sales Market Share Forecast by Application (2022-2027)
Table 116. Global Vigabatrin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 117. Global Vigabatrin Revenue Market Share Forecast by Application (2022-2027)
Table 118. Global Vigabatrin Sales Forecast by Region (2022-2027) & (K Units)
Table 119. Global Vigabatrin Sales Market Share Forecast by Region (2022-2027)
Table 120. Global Vigabatrin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 121. Global Vigabatrin Revenue Market Share Forecast by Region (2022-2027)
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vigabatrin
Figure 2. Global Vigabatrin Market Share by Type in 2020 & 2027
Figure 3. Tablet Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Vigabatrin Market Share by Application in 2020 & 2027
Figure 6. Infantile Spasms (IS)
Figure 7. Partial-Onset Seizures
Figure 8. Refractory Complex Partial Seizures
Figure 9. Global Vigabatrin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Vigabatrin Market Size 2016-2027 (US$ Million)
Figure 11. Global Vigabatrin Sales 2016-2027 (K Units)
Figure 12. Global Vigabatrin Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Vigabatrin Sales Share by Manufacturers in 2020
Figure 14. Global Vigabatrin Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Vigabatrin Players: Market Share by Revenue in 2020
Figure 16. Vigabatrin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Vigabatrin Sales Market Share by Region (2016-2021)
Figure 18. Global Vigabatrin Sales Market Share by Region in 2020
Figure 19. Global Vigabatrin Revenue Market Share by Region (2016-2021)
Figure 20. Global Vigabatrin Revenue Market Share by Region in 2020
Figure 21. U.S. Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Vigabatrin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Vigabatrin by Type (2016-2021)
Figure 46. Sales Market Share of Vigabatrin by Application (2016-2021)
Figure 47. Sales Market Share of Vigabatrin by Application in 2020
Figure 48. Revenue Share of Vigabatrin by Application (2016-2021)
Figure 49. Revenue Share of Vigabatrin by Application in 2020
Figure 50. Manufacturing Cost Structure of Vigabatrin
Figure 51. Manufacturing Process Analysis of Vigabatrin
Figure 52. Vigabatrin Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed